☆ 4.7 Letter

Antibody titers and protection against a SARS-CoV-2 infection

JOURNAL OF INFECTION (2022)

Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France

Chloe Dimeglio et al.

JOURNAL OF INFECTION (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Correlates of protection against SARS-CoV-2 in rhesus macaques

Katherine McMahan et al.

Summary: Adoptive transfer of purified IgG from convalescent macaques protects naive macaques against SARS-CoV-2 infection, and cellular immune responses contribute to protection against rechallenge with SARS-CoV-2. The findings suggest that relatively low antibody titres are sufficient for protection against SARS-CoV-2 in macaques, while higher antibody titres are required for treatment of SARS-CoV-2 infection.

NATURE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

Nicole Doria-Rose et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Emma C. Wall et al.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

The CEPI centralised laboratory network: supporting COVID-19 vaccine development

Arun Kumar et al.

LANCET (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

添加到收藏夹

Article Virology

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens

Pauline Tremeaux et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

添加到收藏夹

Antibody titers and protection against a SARS-CoV-2 infection

相关参考文献

Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France

Correlates of protection against SARS-CoV-2 in rhesus macaques

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

The CEPI centralised laboratory network: supporting COVID-19 vaccine development

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens

导出引文

分享论文